Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Abstract Background Thymidine kinase 1 (TK1) is a cell cycle-regulated enzyme with peak expression in the S phase during DNA synthesis, and it is an attractive biomarker of cell proliferation. Serum TK1 activity has demonstrated prognostic value in patients with early-stage breast cancer. Because cy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nusayba Bagegni, Shana Thomas, Ning Liu, Jingqin Luo, Jeremy Hoog, Donald W. Northfelt, Matthew P. Goetz, Andres Forero, Mattias Bergqvist, Jakob Karen, Magnus Neumüller, Edward M. Suh, Zhanfang Guo, Kiran Vij, Souzan Sanati, Matthew Ellis, Cynthia X. Ma
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-11-01
Colecção:	Breast Cancer Research
Assuntos:	Breast cancer Thymidine kinase Palbociclib Anastrozole Neoadjuvant Biomarker
Acesso em linha:	http://link.springer.com/article/10.1186/s13058-017-0913-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!